TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

Hope for aggressive breast cancer. Survivors and doctors discuss breakthroughs, fears, and the need for inclusive research.

A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC) ...

Breast cancer is the second leading malignant disease in females worldwide. Over decades of research, breast cancer classification by molecular subtypes has ...

Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in ...

Most people with breast cancer get more than one type of treatment, depending on the kind of breast cancer they have and how far it has spread. Certain types of breast cancer, like triple-negative ...

Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.

In December 2022, soon after Reardon’s diagnosis, she and her husband reached out to Kok, who had recently given a TNBC de-escalation presentation at the San Antonio Breast Cancer Symposium.